Investing Profile

Elena Viboch

InvestorVC
Partner at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Partner at General Catalyst

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture

2 Investors

Connected to Saar Gur (CRV), Lisa Marrone (August Capital).

cb
$500K - $2.0M
$500K
11
$1.1B
CompanyStageDateRound SizeTotal Raised
Maxion Therapeutics
Series AMar 2025$75M
$91M
Co-investors: Lucy Edwardes-Jones (Business Growth Fund)
Medeloop
Series ANov 2024$16M
SeedSep 2023$8M
$24M
Co-investors: Sara Thomas Deshpande (Maven Ventures), Magaly Charbonneau (iNovia Capital)
CTRL Therapeutics
SeedApr 2023$10M
$10M
Faro Health
Series AFeb 2023$20M
$35M
Co-investors: Andy Harrison (Section 32)
Paradigm
Series AJan 2023$200M
$240M
Co-investors: Hemant Taneja (General Catalyst), Ramnik Arora (FTX Ventures), Bilal Zuberi (Lux Capital), Stephen Knight (F-Prime Capital Partners), Brett Cook (F-Prime Capital Partners), Alaa Halawa (Mubadala), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Arash Ferdowsi, Eoghan McCabe, Scott Belsky
ArriVent Biopharma
Series BDec 2022$160M
$160M
Co-investors: Carl Gordon (OrbiMed), James Healy (Sofinnova Investments)
Vial
Series BNov 2022$67M
$100M
Co-investors: Josh Buckley (Buckley Ventures), Greg Rosen (BoxGroup), Hemant Taneja (General Catalyst), Nimi Katragadda (BoxGroup), Adam Rothenberg (BoxGroup), David Tisch (BoxGroup), Jeffrey Silverstein (Andreessen Horowitz), Blake Byers (Byers Capital), TJ Nahigian (Base10 (Base10 Partners) ), Zak Kukoff, Gordon Wintrob, Nikhil Krishnan
Odyssey Therapeutics
Series BOct 2022$170M
$490M
Co-investors: Carl Gordon (OrbiMed), Jill carroll (SR One), Lorence Kim (Third Rock Ventures)